The H3K9 Dimethyltransferases EHMT1/2 Protect Against Pathological Cardiac Hypertrophy

Journal of Clinical Investigation - United States
doi 10.1172/jci88353
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Bakuchiol Protects Against Pathological Cardiac Hypertrophy by Blocking NF Kappa B Signaling Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Tripartite Motif 32 Prevents Pathological Cardiac Hypertrophy

Clinical Science
Medicine
2016English

Nuclear GAPDH Signaling Mediates Pathological Cardiac Hypertrophy

2019English

The Transcription Factor GATA-6 Regulates Pathological Cardiac Hypertrophy

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

Activation of Hypoxia-Inducible Factor-2 in Adipocytes Results in Pathological Cardiac Hypertrophy

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2013English

Reversal of Pathological Cardiac Hypertrophy via the MEF2-coregulator Interface

JCI insight
Medicine
2017English

Mechanisms for the Transition From Physiological to Pathological Cardiac Hypertrophy

Canadian Journal of Physiology and Pharmacology
MedicinePhysiologyPharmacology
2020English

Crocetin Protects Against Cardiac Hypertrophy by Blocking MEK-ERK1/2 Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2010English

Fibronectin Contributes to Pathological Cardiac Hypertrophy but Not Physiological Growth

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy